By Editor , 16 September 2026
Clement Auto Group Enters Ohio via Mansfield Motor Group Acquisition

Irvine, Calif. – – September 15, 2026 -- Performance Brokerage Services has brokered the sale of Mansfield Motor Group, a three-rooftop Nissan, Honda and Volvo dealership group in Mansfield, Ohio, from Dirk Schulter and Brett Schulter to Penuel "Raj" Clement of Clement Auto Group.

By Editor , 16 September 2026
Kaiser Permanente Commits $5M to Colorado Schools on Absence Crisis

Denver – – September 15, 2026 -- Kaiser Permanente is committing more than $5 million over the next three years to Colorado school districts, targeting rising student chronic absence and staff burnout that have strained education budgets statewide.

By Editor , 16 September 2026
IPitomy Posts Record 1H '26 Revenue as Clarion Eyes M&A Push

Atlanta – September 15, 2026 -- IPitomy Communications LLC, a subsidiary of Clarion Communications LLC, posted record first-half 2026 results, with adjusted EBITDA climbing 32.8% year-over-year.

Revenue and margins hit first-half highs

Revenue rose 6.4% year-over-year in 1H '26, while gross margin increased 2.6% over the same period. Sales bookings grew 10.9% year-over-year, marking the strongest first-half sales pipeline in the company's history.

By Editor , 16 September 2026

Boston – September 15, 2026 -- Aerospace & Defense M&A deal value jumped 37% year-over-year in the first quarter of 2026 to $47.1 billion in disclosed enterprise value, according to Capstone Partners' annual Aerospace, Defense, Government & Security (ADGS) Industry M&A Report.

By Editor , 16 September 2026
Haivision Q3 Revenue Slips 1.4% as Supply Chain Squeezes Margins

Montreal – September 15, 2026 -- Haivision Systems Inc. (TSX: HAI) reported third-quarter revenue of $34.5 million, down 1.4% year-over-year, as gross margins compressed to 69.4% from 72.0% amid escalating component costs and supply-chain disruptions.

By Editor , 16 September 2026
CBS ArcSafe Launches Remote Racking System for Toshiba VY Breakers

Denton, Texas – September 15, 2026 -- CBS ArcSafe has introduced the RRS-3 VY Toshiba, a remote racking system that lets technicians operate Toshiba VY-30M25A circuit breakers from up to 300 feet away, keeping crews outside the arc flash boundary.

System eliminates manual contact during breaker racking operations

The RRS-3 VY Toshiba handles rotary racking only and requires no modifications to existing switchgear. Because operators never make manual contact with the gear during racking, the system reduces or eliminates the need for arc flash hazard suits.

By Editor , 16 September 2026
Trilogy Metals Shares Surge 570% Over Three Years, Lands on TSX30

Vancouver – September 15, 2026 -- Trilogy Metals Inc. (NYSE American: TMQ; TSX: TMQ) has been named to the 2026 TSX30, the Toronto Stock Exchange's annual ranking of top-performing listed companies, after its share price climbed 570% over the three years ended June 30, 2026.

TSX30 ranking measures three-year dividend-adjusted share price gains

The TSX30 list ranks companies by dividend-adjusted share price appreciation over a rolling three-year window. Trilogy's 570% gain places it among the exchange's top performers for the period.

By Editor , 16 September 2026
Hycroft Drills 30.5 Meters of 780.53 g/t Silver at Nevada's Vortex Zone

Winnemucca, Nev. – September 15, 2026 -- Hycroft Mining Holding Corporation (Nasdaq: HYMC) reported drill hole H26D-6090 returned 30.5 meters grading 780.53 g/t silver and 0.49 g/t gold at its Vortex zone in Nevada, among the strongest intercepts yet from its 2025-2026 Exploration Drill Program.

By Editor , 15 September 2026

Durham – September 15, 2026 -- Seismic Pharmaceuticals has commenced a global Phase 3 trial of Istaroxime, aiming to deliver the first-ever approved drug for cardiogenic shock, a condition with no currently FDA-approved treatments.

Trial to enroll 600 patients across three continents

The study, named Rescue HF CS, will recruit approximately 600 patients at clinical sites in the United States, Europe and South America. It builds on four completed Phase 2 trials in which more than 340 patients received Istaroxime.